Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stroke study backs Radiant's brain cooling technology:

This article was originally published in Clinica

Executive Summary

Radiant Medical has reported promising results from a trial to assess its Reprieve endovascular temperature therapy system in treating ischaemic stroke patients through cooling. The 40-patient study, COOL-AID II, which the firm claims is the first to use the blood-cooling technology in stroke patients, showed that cooling patients' brains to 33 degrees C (mild hypothermia) for 24 ours led to a trend towards reduced brain tissue damage, says the Redwood City, California firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061360

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel